Organization Profile

You just read:

Anavex reports ANAVEX 2-73 blocks Tau and Amyloid-Beta Proteins in a Preclinical Model of Alzheimer's Disease

News provided by

Anavex Life Sciences Corp.

Nov 04, 2013, 07:30 ET